血小板糖蛋白 Ibα 细胞质尾部 恶化 血栓形成 在细菌性败血症期间
Yue Xia1, Chenglin Sun1, Kangxi Zhou1
1Jiangsu Institute of Hematology, Cyrus Tang Medical Institute, Suzhou Medical College of Soochow University, NHC Key Laboratory of Thrombosis and Hemostasis, National Clinical Research Center for Hematological Diseases, Suzhou 215123, China.
International journal of molecular sciences
|November 9, 2024
概括
血小板GPIbα细胞质尾部通过通过蛋白质激酶C (PKC) 增加血小板激活和炎症来加剧败血症. 抑制PKC或这个尾巴改善了败血症小鼠的结果.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 患有扩散性血管内凝血 (DIC) 和血小板狭窄症的败血症患者面临着不良预后.
- 血小板糖蛋白Ibα (GPIbα) 在血栓形成,血液静止和炎症中起作用.
- GPIbα细胞质尾在败血症诱导的血小板激活和炎症中的作用尚不清楚.
研究的目的:
- 调查GPIbα细胞质尾巴是否调节败血症介导的血小板激活和炎症,特别是在金黄色葡萄球菌和大肠杆菌感染中.
主要方法:
- 使用了一种老鼠模型,对 Staphylococcus aureus 诱导的细菌血症进行了研究.
- 研究了10氨基酸缺乏在GPIbα C-终端序列中的影响.
- 评估了药理上抑制蛋白激酶C (PKC) 的影响.
主要成果:
- 缺乏GPIbα C-终端序列和PKC抑制减少了血小板激活和聚合.
- GPIbα细胞质尾巴增强了库普费尔细胞的血小板细胞化.
- GPIbα细胞质尾部的遗传缺陷降低了炎症性细胞因子,肝损伤,并改善了生存率.
结论:
- 血小板GPIbα细胞质域通过PKC依赖的途径加剧与败血症相关的血小板激活和炎症.
- 准GPIbα细胞质尾巴或使用PKC抑制剂可能为细菌感染提供治疗策略.
相关概念视频
01:22Formation of the Platelet Plug
4.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.6K
01:18Structure and Function of Platelets
1.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.0K
01:17Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
01:16Clot Retraction and Fibrinolysis
4.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.7K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
471
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
471